DHR

DanaherA

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

Materiality

Source

External coverage

Decided

2026-10-21

Danaher ( NYSE : DHR ) Announces Quarterly Earnings Results , Beats Estimates By $0 . 19 EPS

Danaher beat Q3 adjusted EPS estimates by $0.19 and raised its full-year 2026 adjusted EPS guidance; the company also reported improving end-market trends. Positive issuer read-through, though this artifact centers on earnings and guidance rather than a durable thesis change.

View event details

Sentiment decomposition

+0.3

30-day score

Company-55%

Macro-30%

Pulse-15%

Weekly research-10-day

Company, Macro, and Pulse form the existing 30-day artifact blend. Weekly research is tracked separately for 10 days and can contribute at most 10% of the sentiment pillar when live mode is enabled.

Recent headlines

No supplemental ticker headlines stored yet

We are still collecting relevant articles for DHR. Curated events highlight the most material developments impacting this ticker right now.

Check curated events Open full news archive

As of 2026-10-21 • Updated scheduledSource: News desk